NOVARTIS AG |
Market Closed -
Other stock markets
|
Pre-market 07:00:46 | |||
| 102 USD | -0.86% |
|
102.2 | +0.22% |
| 08:07am | NOVARTIS AG : Berenberg remains Neutral | ZD |
| 06:01am | Novartis' Cosentyx Receives Canadian Approval for Hidradenitis Suppurativa Treatment | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 723B | ||||||
| 595B | ||||||
| 369B | ||||||
| 332B | ||||||
| 282B |
